GCNT2 and acute myeloid leukemia: Four independent studies covering a total of 2033 AML samples were selected in cBioPortal, among which, genetic alteration of GCNT2 was detected in 1 out of 1083 profiled samples (ratio: 0.1%) (Figure 4), therefore, we are able to conclude that regulation of GCNT2 in AML may occur beyond GCNT2 mutation.